Navigation Links
Women's World Banking Welcomes New Network Member From Tunisia
Date:9/10/2007

Enda Inter-Arabe Is a Leader in Supporting Women's Emancipation Through

Economic Participation

NEW YORK, Sept. 10 /PRNewswire-USNewswire/ -- The power of microfinance to provide better economic opportunities for low-income entrepreneurs is emerging in the Arab world. Tunisia is the third Arab country, after Jordan and Morocco, to be represented in the WWB network. In all, WWB's three Arab network members serve more than 480,000 low-income clients in the region, most of them women.

"Money is important for people, but for centuries Muslim women didn't have access to money and so it was easy to exploit them," says Essma Ben Hamida, Co-Director of Enda Inter-Arabe, the first and largest microfinance institution in Tunisia and Women's World Banking's newest network member organization. "When women are less poor, when they have access to money, they can improve their living conditions -- their housing, the education of their children -- and they are less vulnerable."

"WWB is excited to welcome Enda Inter-Arabe as our first new network member in four years," says WWB President Mary Ellen Iskenderian. "This is a major step in our planned expansion of microfinance in the Middle East."

Enda I-A was created in 1990 as a branch of Enda Third World, the Environment and Development Action agency based in Dakar, Senegal, with affiliates in 21 countries. Since its founding, Enda I-A has demonstrated that when women have access to business capital and to training, their self- confidence and horizons expand; the quality of life of their families improves and they feel they have a stake in preserving the stability of their communities.

One sign of economic growth among Enda's 54,000 clients -- 85% percent of whom are women -- is that an increasing number of them are requesting larger, individual loans rather than the smaller group loans that are typically given to first-time borrowers. In addition to business credit, hou
'/>"/>

SOURCE Women's World Banking
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Young womens woes
2. Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies
3. Diabetic Womens Death Rate Shows No Decline
4. Rare Womens Lung Disease May Yield Insights Into Common Diseases
5. Womens Mood Plays a Key Role in Infertility Treatment
6. Oracle Corp. to help build worlds first "Digital Hospital"
7. The World Bank funds private Hospital in India
8. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
9. Half of worlds children are passive smokers - damning disclosure from WHO
10. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
11. Televisions ruling babys world!

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... announced that it has become a national sponsor o...profit organizations dedicated to arthritis resear... Delray Beach, FL (Vocus) November 27, 200...any specializing in the marketing and retail distr...nced today that is has become a national sponsor o...
(Date:11/27/2009)...conomic burdens, study predicts , , FRID...le with diabetes in the United States is expected ...icts. , That would bring the total by 2034 to a... 23.7 million today. , , At the same time, the c...the study also warns, rising from an estimated $11...
(Date:11/27/2009)...announced today that Spectrum Health (Grand Rapids...orthopedic templating solution and its TraumaCad E... (PRWEB) November 27, 2009 -- Voyant Health&trade...ds, Michigan) has licensed its TraumaCad Enterpris... Extend workflow solution, to allow its orthopedic...
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...fluseasonuponus,it,smoreimportantthanevertoemployg...illness. ,, "Weneedtobeproactivenotonlytokeepou...esick,"saidEileenFinerty,RN,MS,CIC(certifiedininfe...ndoccupationalhealthatHospitalforSpecialSurgery(HS...neofthelowestinfectionratesofanyhospitalinthecount...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3
...ELPHIA (January 22, 2008) -- Researchers from the ...have used a novel molecular method to identify che...man bitter taste receptors. , The findings, publ...ste in particular. , Identification of bitter t...
...chers in the Department of Medicine and Department...e have discovered that chronic pain can be success... an effort to find a more effective treatment for ...ensory neuron targeting by self-complementary AAV8...
...da, MD (Jan. 18, 2008) The use of regular, long-t...ugs (NSAIDs) reduces the risk associated with colo...Gastroenterology , the official journal of the Ame... at doses that are higher than recommended over a ...
...l, January 22, 2007 An international research tea...de lUniversit de Montral (CHUM), has identified ne...e sclerosis (MS). In the February issue of Nature ... the nervous system that affects approximately 55,...
...dies sense painful stimuli through certain recepto...l organs. Specialized nerve fibers relay these sig... pain becomes conscious. The spinal cord is placed...nd at the Institute of Pharmacology and Toxicology...
...taking Nexavar need to be monitored closely, study...) -- ,A drug that prolongs the lives of patients w... of developing high blood pressure. , Patients ta...logy . , Nexavar is an anti-angiogenesis drug, mea...
Other Medicine News:Health News:Food peptides activate bitter taste receptors 2Health News:Researchers find relief for chronic pain 2Health News:Regular, long-term aspirin use reduces risk of colorectal cancer 2Health News:New therapeutic target for treatment of multiple sclerosis 2Health News:Nature publication on pain research 2Health News:Liver Cancer Drug Raises Blood Pressure 2
(Date:11/25/2009)...Calif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,ann...ny,sPROTECT-1(theProspectiveRandomizedOralTherapyE...CX282-B)inpatientswithmoderate-to-severeCrohn,sdis...tyandtolerabilityprofile.Thestudydemonstratedevide...tyasdefinedasa70-pointdecreaseintheCrohn,sDiseaseA...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasd...oraorticdisorders,announcedtodaythatithasfiledamot...nfringementlawsuitbroughtagainstitinOctober2009byC...CourtinIndianapolis,Indiana. ,, Endologixhasreq...sPatentandTrademarkOffice(USPTO)conductsproceeding...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--AnadysPharmaceuticals,In...the21stAnnualPiperJaffrayHealthcareConferenceonTue...onferenceisbeingheldatTheNewYorkPalaceHotel.SteveW...adys,willprovideanoverviewofAnadysanditsclinicalde...atepresentationwillbesimultaneouslywebcastandcanbe...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2AMT Provides Business Update for the Third Quarter 2009 14895 1AMT Provides Business Update for the Third Quarter 2009 14895 2AMT Provides Business Update for the Third Quarter 2009 14895 3AMT Provides Business Update for the Third Quarter 2009 14895 45 exercises can reduce neck shoulder pain of women office workers 10780 15 exercises can reduce neck shoulder pain of women office workers 10780 25 exercises can reduce neck shoulder pain of women office workers 10780 3BioSoteria CEO to Present at Drug Safety Conference 14889 1BioSoteria CEO to Present at Drug Safety Conference 14889 2
...ENEVA, April 20, 2007 /PRNewswire/ -- Addex Pharma...n of a Phase IIa proof of,concept trial with its l...he study achieved its primary objective, the absen...al significance, and,also showed trends towards im...igraine pain at other time points. ADX10059 has,al...
...ATTLE--(BUSINESS WIRE)--Apr 19, 2007 - Gilead Scie...results of its Phase III,AIR-CF2 study evaluating ... patients with cystic fibrosis (CF) who have,pulmo...e study, a,28-day treatment course of aztreonam ly...nhaled or intravenous (IV) antibiotics versus,plac...
Other Medicine Technology:Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7
Atria 3100 ECG
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: